Prevalence and characteristics of hereditary non-polyposis colorectal cancer (HNPCC) syndrome in immigrant Asian colorectal cancer patients

被引:13
|
作者
Lee, Jasmine [1 ]
Xiao, Yin-Yi [2 ]
Sun, Yan Yu [3 ]
Balderacchi, Jasminka [4 ]
Clark, Bradley [5 ]
Desani, Jatin [6 ]
Kumar, Vivek [7 ]
Saverimuthu, Angela [1 ]
Win, Khin Than [8 ]
Huang, Yiwu [1 ]
Xu, Yiqing [1 ]
机构
[1] Maimonides Hosp, Dept Internal Med, Div Hematol & Oncol, 6300 8th Ave, Brooklyn, NY 11220 USA
[2] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Pittsburgh, PA 15261 USA
[3] Maimonides Hosp, Dept Pathol, 4802 10th Ave, Brooklyn, NY 11219 USA
[4] CBLPath, 760 Westchester Ave, Rye Brook, NY 10573 USA
[5] Womans Hlth Labs, 3495 Hacks Cross Rd, Memphis, TN 38125 USA
[6] Meridian Med Grp Specialty Care, 1100 Route 72 West,Suite 201, Manahawkin, NJ 08050 USA
[7] Brigham & Womens Hosp, Dept Internal Med, 75 Francis St, Boston, MA 02115 USA
[8] 115 St Nicholas Ave, Brooklyn, NY 11237 USA
来源
BMC CANCER | 2017年 / 17卷
关键词
Hnpcc; Asian; Colorectal cancer; Lynch syndrome; Screening; MICROSATELLITE-INSTABILITY; MISMATCH-REPAIR; LYNCH-SYNDROME; FEASIBILITY; CRITERIA; STRATEGY; TUMORS;
D O I
10.1186/s12885-017-3799-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The prevalence of Hereditary Non-Polyposis Colorectal Cancer (HNPCC) is 2 to 5% in the Caucasian population. HNPCC is caused by genomic mutations in DNA mismatch repair genes (MMR), namely MLH1, MSH2, MSH6, PMS2, and EPCAM. A non-hereditary, acquired process of hypermethylation of the MLH1 promoter can also lead to silencing of MLH1 protein expression. Diagnosis of HNPCC in patients with colorectal and other related cancers is important in the clinical treatment and surveillance of related cancers. The prevalence and clinical characteristics of HNPCC in Asian colorectal cancer patients has been reported in small studies and unique features have been suggested. Methods: We retrospectively reviewed the clinical characteristics of Asian patients who were diagnosed of colon cancer between 1/2002 and 6/2015, and performed IHC for four MMR protein expressions on tumor specimens as a screening test for HNPCC, followed by confirmatory tests of genomic sequencing and hypermethylation analysis. Results: One hundred forty-three patients were identified. Thirty-one patients were diagnosed younger than 50 years old, while 112 patients were diagnosed older than 50 years old. Six cases of HNPCC were found with a prevalence of 4. 19%. The prevalence in the group of patients diagnosed younger than 50 years old is 16.1%, and that in patients diagnosed older than 50 years old is 0.89%. All patients with HNPCC had family histories of colon or gastric cancer. Tumor locations in the HNPCC patients were predominantly in the descending or sigmoid colon (67%). Half of the HNPCC patients had MSH6 mutations. Hypermethylation of the MLH1 gene was only present in 2.80% of the patients. Conclusion: The prevalence of HNPCC is high in patients younger than 50 years old and extremely low in those older than 50 years old. These results may be useful in the future development of guidelines for HNPCC laboratory screening among Asian patients. The pathological and clinical features of HNPCC in this group of Asian immigrant patients are more similar to those reported on Asian patients in their home countries than to Caucasian patients in Western countries, and will warrant further large-scale evaluation.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Prevalence and characteristics of hereditary non-polyposis colorectal cancer (HNPCC) syndrome in immigrant Asian colorectal cancer patients
    Jasmine Lee
    Yin-Yi Xiao
    Yan Yu Sun
    Jasminka Balderacchi
    Bradley Clark
    Jatin Desani
    Vivek Kumar
    Angela Saverimuthu
    Khin Than Win
    Yiwu Huang
    Yiqing Xu
    BMC Cancer, 17
  • [2] Prevalence of hereditary non-polyposis colorectal cancer (HNPCC) in Czech patients with endoscopic diagnosis of colorectal cancer
    Hajer, J
    Zádorová, Z
    Kment, M
    Faltyn, J
    8TH BIENNIAL CONGRESS OF THE EUROPEAN COUNCIL OF COLOPROCTOLOGY (ECCP), 2001, : 219 - 224
  • [3] Mismatch repair and the hereditary non-polyposis colorectal cancer syndrome (HNPCC)
    Müller, A
    Fishel, R
    CANCER INVESTIGATION, 2002, 20 (01) : 102 - 109
  • [4] Bleomycin sensitivity in patients with hereditary non-polyposis colorectal cancer (HNPCC)
    Kladny, J
    Zajaczek, S
    Lubinski, J
    CYTOGENETICS AND CELL GENETICS, 1997, 77 (1-2): : P367 - P367
  • [6] Risk of Hereditary Non-polyposis Colorectal Cancer (HNPCC) in patients with colorectal adenomas.
    Andreu, M
    Vazquez, E
    Delgado, S
    Gallen, M
    Panades, A
    Bory, F
    Vila, C
    Coll, S
    Sola, R
    GASTROENTEROLOGY, 1998, 114 (04) : A557 - A557
  • [7] Diagnosis of hereditary non-polyposis colorectal cancer (HNPCC) - Reply
    Roncucci, L
    de Leon, MP
    Benatti, P
    Borghi, F
    Pedroni, M
    Scarselli, A
    di Gregorio, C
    Losi, L
    Viel, A
    Genuardi, M
    Abbati, G
    Rossi, G
    Menigatti, M
    Ponti, G
    GUT, 2004, 53 (07) : 1055 - 1056
  • [8] Molecular genetics of hereditary non-polyposis colorectal cancer (HNPCC)
    Cama, A
    Genuardi, M
    Guanti, G
    Radice, P
    Varesco, L
    TUMORI JOURNAL, 1996, 82 (02): : 122 - 135
  • [9] Comparison of Survival between Patients with Hereditary Non-polyposis Colorectal Cancer (HNPCC) and Sporadic Colorectal Cancer
    Haghighi, Mahdi Montazer
    Vahedi, Mohsen
    Mohebbi, Seyed Reza
    Pourhoseingholi, Mohamad Amin
    Fatemi, Seyed Reza
    Zali, Mohammad Reza
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2009, 10 (02) : 209 - 212
  • [10] Hereditary non-polyposis colorectal cancer syndrome
    Moore, J
    Cowled, P
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1999, 69 (01): : 6 - 13